Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs
The COVID-19 pandemic has disrupted life throughout the world. Newly developed vaccines promise relief to people who live in high-income countries, although vaccines and expensive new treatments are unlikely to arrive in time to help people who live in low-and middle-income countries. The pathogenes...
Saved in:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Book |
| Published: |
Taylor & Francis Group,
2021-09-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_ff57e9a8a0804bfb943dca9ad4ae5f98 | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Geert Byttebier |e author |
| 700 | 1 | 0 | |a Luc Belmans |e author |
| 700 | 1 | 0 | |a Myriam Alexander |e author |
| 700 | 1 | 0 | |a Bo E. H. Saxberg |e author |
| 700 | 1 | 0 | |a Bart De Spiegeleer |e author |
| 700 | 1 | 0 | |a Anton De Spiegeleer |e author |
| 700 | 1 | 0 | |a Nick Devreker |e author |
| 700 | 1 | 0 | |a Jens T. Van Praet |e author |
| 700 | 1 | 0 | |a Karolien Vanhove |e author |
| 700 | 1 | 0 | |a Reinhilde Reybrouck |e author |
| 700 | 1 | 0 | |a Evelien Wynendaele |e author |
| 700 | 1 | 0 | |a David S. Fedson |e author |
| 245 | 0 | 0 | |a Hospital mortality in COVID-19 patients in Belgium treated with statins, ACE inhibitors and/or ARBs |
| 260 | |b Taylor & Francis Group, |c 2021-09-01T00:00:00Z. | ||
| 500 | |a 2164-5515 | ||
| 500 | |a 2164-554X | ||
| 500 | |a 10.1080/21645515.2021.1920271 | ||
| 520 | |a The COVID-19 pandemic has disrupted life throughout the world. Newly developed vaccines promise relief to people who live in high-income countries, although vaccines and expensive new treatments are unlikely to arrive in time to help people who live in low-and middle-income countries. The pathogenesis of COVID-19 is characterized by endothelial dysfunction. Several widely available drugs like statins, ACE inhibitors (ACEIs) and angiotensin receptor blockers (ARBs) have immunometabolic activities that (among other things) maintain or restore endothelial cell function. For this reason, we undertook an observational study in four Belgian hospitals to determine whether in-hospital treatment with these drugs could improve survival in 959 COVID-19 patients. We found that treatment with statins and ACEIs/ARBs reduced 28-day mortality in hospitalized COVID-19 patients. Moreover, combination treatment with these drugs resulted in a 3-fold reduction in the odds of hospital mortality (OR = 0.33; 95% CI 0.17-0.69). These findings were in general agreement with other published studies. Additional observational studies and clinical trials are needed to convincingly show that in-hospital treatment with statins, ACEIs/ARBs, and especially their combination saves lives. | ||
| 546 | |a EN | ||
| 690 | |a covid-19 | ||
| 690 | |a mortality | ||
| 690 | |a propensity score | ||
| 690 | |a case-control | ||
| 690 | |a statins | ||
| 690 | |a ace inhibitors | ||
| 690 | |a angiotensin receptor blockers | ||
| 690 | |a immunometabolism | ||
| 690 | |a Immunologic diseases. Allergy | ||
| 690 | |a RC581-607 | ||
| 690 | |a Therapeutics. Pharmacology | ||
| 690 | |a RM1-950 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Human Vaccines & Immunotherapeutics, Vol 17, Iss 9, Pp 2841-2850 (2021) | |
| 787 | 0 | |n http://dx.doi.org/10.1080/21645515.2021.1920271 | |
| 787 | 0 | |n https://doaj.org/toc/2164-5515 | |
| 787 | 0 | |n https://doaj.org/toc/2164-554X | |
| 856 | 4 | 1 | |u https://doaj.org/article/ff57e9a8a0804bfb943dca9ad4ae5f98 |z Connect to this object online. |